Literature DB >> 932174

The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.

S E Crockett, S Cataland, J M Falko, E L Mazzaferri.   

Abstract

Intravenously administered porcine GIP is insulinotropic in man. This study was designed to investigate the effects of simultaneous fat ingestion, a potent stimulus for GIP release, and intravenous glucose infusion upon endogenous serum GIP and insulin concentrations in normal subjects. Seven normal volunteers were studied on three separate occasions following: a) the ingestion of 67 grams of emulsified corn oil, b) constant intravenous infusion of glucose, and c) simultaneous administration of corn oil and glucose as in parts (a) and (b) of the study. Serum glucose, insulin (IRI), and GIP concentrations were measured at intervals between 15 and 180 minutes following each stimulus. With corn oil, mean serum GIP concentrations increased from a fasting level of 290 +/- 40 (SE) pg/ml to 1936 +/- 402 pg/ml at 60 minutes without a significant change in serum IRI or glucose concentrations. The infusion of intravenous glucose alone was associated with no rise in serum GIP levels despite a substantial increase in serum IRI and glucose concentrations. With the combined stimuli, mean serum GIP increased less (P is less than .05) between 30 and 90 minutes, and total integrated incremental GIP was significantly less (P is less than .025) than that after corn oil ingestion alone. Following the combined stimuli, incremental insulin levels were higher (P is less than .05) between 15 and 90 minutes, total integrated incremental insulin was greater (P is less than .025), and glucose homeostasis was significantly enhanced (P is less than .05) at 120 and 180 minutes compared with the effects on insulin of glucose infusion alone. We conclude that the potentiation of glucose-stimulated insulin secretion induced by the ingestion of fat is associated with serum GIP levels that are within the insulinotropic range. The augmented secretion of insulin may be mediated partially or completely by endogenous GIP. The lower serum GIP concentrations observed following the combined stimuli suggest a feedback inhibition of GIP release which is perhaps mediated by insulin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932174     DOI: 10.1210/jcem-42-6-1098

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

Review 2.  New developments in the incretin concept.

Authors:  W Creutzfeldt; R Ebert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

Review 3.  Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.

Authors:  A Zarrinpar; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-10-11       Impact factor: 8.171

4.  GIP and the metabolic response to carbohydrate and fat.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

5.  Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels.

Authors:  W Creutzfeldt; R Ebert; B Willms; H Frerichs; J C Brown
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

6.  Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation of food restriction.

Authors:  B Willms; R Ebert; W Creutzfeldt
Journal:  Diabetologia       Date:  1978-06       Impact factor: 10.122

7.  Adrenergic modulation of gastric inhibitory polypeptide secretion in man.

Authors:  M Salera; R Ebert; P Giacomoni; L Pironi; S Venturi; R Corinaldesi; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

8.  Pancreatic islet hormone response to oral glucose in morbidly obese patients.

Authors:  K R Sirinek; T M O'Dorisio; B Howe; A S McFee
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

9.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 10.  Clinical aspects of GIP secretion.

Authors:  B Beck; C Villaume; G Debry
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.